These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21134551)

  • 1. Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma.
    Lang BH; Lo CY; Wong IO; Cowling BJ
    Surgery; 2010 Dec; 148(6):1191-6; discussion 1196-7. PubMed ID: 21134551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
    Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers.
    Al-Qahtani KH; Al-Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Al-Hussain H; Maklad AM
    Saudi Med J; 2015 Apr; 36(4):442-8. PubMed ID: 25828281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
    Bhattacharyya N; Chien W
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
    Gandhi S; Abhyankar A; Basu S
    Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
    Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
    Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
    Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
    Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
    Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study.
    Piscopo L; Volpe F; Nappi C; Zampella E; Manganelli M; Matrisciano F; Totaro P; Pace L; Maurea S; Cuocolo A; Klain M
    Curr Oncol; 2022 Dec; 30(1):37-44. PubMed ID: 36661652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
    Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
    Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
    Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
    Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma.
    Lang BH; Wong KP
    Ann Surg Oncol; 2011 Dec; 18(13):3559-65. PubMed ID: 21573833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
    White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
    Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazard ratios of second primary malignancy after radioiodine for differentiated thyroid carcinoma: a large-cohort retrospective study.
    Wu W; Li S; Xu K; Meng Z
    Endokrynol Pol; 2023; 74(3):260-270. PubMed ID: 37335064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
    Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer following differentiated thyroid cancer.
    Berthe E; Henry-Amar M; Michels JJ; Rame JP; Berthet P; Babin E; Icard P; Samama G; Galateau-Sallé F; Mahoudeau J; Bardet S
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):685-91. PubMed ID: 14747959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity.
    Wong RL; Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Aug; 19(8):2635-42. PubMed ID: 22526904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.